CAPN2 and glioblastoma: These findings have future implications for the clinical management of patients: based on our results, GBM patients with high calpain-2 levels should be stratified and subjected to anti-calpain-2 treatment in combination with TMZ to achieve a tailored therapy and a better outcome.